Boluoke®
R3,160.38
Healthy Coagulation & Biofilm Defence
Features & Benefits
Boluoke® is the only fully researched oral fibrinolytic supplement on the market. Besides having in vitro studies, animal studies, toxicity studies, and pharmacokinetic studies done, Boluoke® has also been put through all phases of clinical trials (including randomised double blind controlled studies). Boluoke® is the only Lumbrokinase that is backed by Phase I-III clinical trials.
Suggested Use
As a dietary supplement, if Boluoke® is to be taken for chronic conditions, it should be taken at the dose of 1 capsule one to three times daily 30 minutes before the meal. However, the practitioner may recommend 2 capsules three times daily for 3 to 6 weeks in conditions with severe hypoperfusion.
Cautions
Lumbrokinase strongly inhibits adhesion molecules on platelets. Thus it is advised that
lumbrokinase not be taken concurrently with other strong antiplatelet medications like
Plavix® or Ticlid®. General contra-indications for Boluoke® are: allergy to lumbrokinase
or earthworm; recent surgery, lumbar puncture, or arterial puncture; trauma; aneurysm;
active internal bleeding or GI ulceration; or any other bleeding disorders. The patient should
stop Boluoke® 1 week prior to surgery, and should be able to resume taking Boluoke® 15
days after surgery or at the physician’s discretion.
OTHER INGREDIENTS: Acid resistant hypromellose capsules, microcrystaline cellulose.
Additional information
| Capsules | 120, 60 |
|---|
Reviews
There are no reviews yet.